Emrock Corporation Limited (formerly Vaghani Techno - Build Limited) has announced the outcome of its Board of Directors meeting held on May 12, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board considered and approved the standalone audited financial results for the fourth quarter and year ended March 31, 2026, along with the Statement of Assets and Liabilities and the Audit Report issued by the Statutory Auditor. The Statutory Auditor's report carries an Unmodified Opinion with respect to the audited financial statements. The board meeting commenced at 4:00 PM and concluded at 6:00 PM (IST). Subsequently, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published newspaper advertisements for the audited financial results in Free Press Gujarat (English newspaper) and Lokmitra (Gujarati newspaper) on May 14, 2026.

Financial Performance: Full Year and Q4 FY26

Emrock Corporation delivered a strong financial performance for FY26, with total revenue and profitability rising sharply on a year-on-year basis. The following table presents the key financial metrics for the quarter and year ended March 31, 2026 (₹ in Lakhs):

For the full year FY26, total revenue grew to ₹268.17 lakhs from ₹67.40 lakhs in FY25, while net profit surged to ₹121.02 lakhs compared to ₹17.00 lakhs in the prior year. The paid-up equity share capital stood at ₹1,582 lakhs (face value of ₹10 per share) as at March 31, 2026, compared to ₹522 lakhs in the previous year. The board has not recommended any final dividend for the financial year ended March 31, 2026.

Segment-Wise Performance

The company operates across three reportable segments — Real Estate, Solar, and Hospitality — as identified in accordance with Ind AS 108. The segment-wise revenue and results for the quarter and year ended March 31, 2026 are presented below (₹ in Lakhs):

The Real Estate segment was the largest revenue contributor for FY26 at ₹146.80 lakhs, followed by Solar at ₹59.00 lakhs. Segment assets rose significantly to ₹1,854.73 lakhs as at March 31, 2026, from ₹0.52 lakhs in the prior year, driven primarily by Solar Business assets of ₹1,436.70 lakhs and Real Estate assets of ₹365.00 lakhs.

Balance Sheet and Cash Flow Highlights

The company's total assets expanded substantially to ₹3,479.37 lakhs as at March 31, 2026, from ₹830.58 lakhs in the previous year, reflecting significant investment activity. Key balance sheet and cash flow metrics are summarised below (₹ in Lakhs):

The significant increase in investing outflows of ₹2,182.63 lakhs in FY26 was primarily on account of investment in Capital Work in Progress of ₹1,430.14 lakhs and Other Non-Current Assets of ₹751.54 lakhs. Financing activities generated ₹2,178.22 lakhs, supported by proceeds from borrowings of ₹965.56 lakhs and money received against share warrants and conversion of share warrants to equity of ₹1,521.73 lakhs. The financial results were audited by Purushottam Khandelwal & Co., Chartered Accountants (FRN: 0123825W), and reviewed by the Audit Committee prior to board approval.

Regulatory Compliance

In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emrock Corporation published newspaper advertisements disclosing the audited standalone financial results for the quarter and year ended March 31, 2026. The advertisements were published on May 14, 2026, in the following publications:

The financial results, along with the Audit Report, have also been posted on the company's website at www.emrockgroup.com and on the BSE website at www.bseindia.com .

Emrock Corporation Limited has announced a strategic move into the pharmaceutical and healthcare sector through the incorporation of a Limited Liability Partnership (LLP). The Board of Directors approved this initiative at its meeting held on May 12, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made to BSE Limited as part of the company's regulatory obligations.

Strategic Expansion into Pharmaceutical Sector

The company, formerly known as Vaghani Techno - Build Limited, has identified the pharmaceutical and healthcare sector as one of its main business objectives. The proposed LLP will be incorporated in association with other partner(s) to undertake a broad range of business activities within this domain. This move represents a significant diversification initiative for the company.

The key details of the proposed LLP incorporation are outlined below:

Scope of Proposed LLP Business Activities

The proposed LLP is set to engage in a wide range of activities within the pharmaceutical domain. The business activities include:

• Pharmaceutical products development and supply
• Healthcare solutions provision
• Trading and marketing of pharmaceutical products
• Manufacturing of pharmaceutical goods
• Distribution across relevant markets
• Import and export of pharmaceutical products
• Allied activities within the pharmaceutical domain

Regulatory Compliance and Next Steps

Emrock Corporation has stated that the necessary details as required under SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, will be disseminated in due time upon issuance of the Certificate of Incorporation by the appropriate authority. The disclosure was signed by Managing Director Jatinkumar Tulsibhai Patel (DIN: 01473158) from Ahmedabad on May 12, 2026. The company has requested BSE Limited to take the disclosure on record.